News
MYNZ
1.175
-6.75%
-0.085
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 2d ago
Mainz Biomed expects to complete eAArly DETECT 2 study in 2026
TipRanks · 3d ago
Weekly Report: what happened at MYNZ last week (1229-0102)?
Weekly Report · 3d ago
Mainz Biomed Provides Review of 2025 Highlights
Barchart · 4d ago
Weekly Report: what happened at MYNZ last week (1222-1226)?
Weekly Report · 12/29/2025 09:13
Weekly Report: what happened at MYNZ last week (1215-1219)?
Weekly Report · 12/22/2025 09:13
Weekly Report: what happened at MYNZ last week (1208-1212)?
Weekly Report · 12/15/2025 09:15
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 12/10/2025 21:05
Weekly Report: what happened at MYNZ last week (1201-1205)?
Weekly Report · 12/08/2025 09:14
Mainz Biomed files $150M mixed securities shelf
TipRanks · 12/05/2025 22:10
Mainz Biomed announces ColoAlert added to portfolio of DoctorBox
TipRanks · 12/02/2025 13:27
Weekly Report: what happened at MYNZ last week (1124-1128)?
Weekly Report · 12/01/2025 09:14
Mainz Biomed B.V. Amends Articles to Boost Share Capital
TipRanks · 11/26/2025 22:27
Weekly Report: what happened at MYNZ last week (1117-1121)?
Weekly Report · 11/24/2025 09:15
Mainz Biomed, OncoVanguard8 agree to bring ColoAlert to South America
TipRanks · 11/18/2025 14:30
Weekly Report: what happened at MYNZ last week (1110-1114)?
Weekly Report · 11/17/2025 09:14
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 11/13/2025 17:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 11/13/2025 12:06
Mainz Biomed To Present Flagship Product, ColoAlert, At MEDICA 2025
NASDAQ · 11/12/2025 14:25
Mainz Biomed Showcases Innovative Cancer Detection Solutions at MEDICA 2025
Barchart · 11/12/2025 07:01
More
Webull provides a variety of real-time MYNZ stock news. You can receive the latest news about Mainz Biomed NV through multiple platforms. This information may help you make smarter investment decisions.
About MYNZ
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.